2B-trans™ technology: Targeted drug delivery across the blood-brain barrier

Methods in Molecular Biology

Volumn 437, Issue , 2008, Pages 161-175

  Gaillard, Pieter J ^a   De Boer, Albertus G ^b  

^a Bio Science Park Leiden   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Astrocytes; Blood brain barrier; Brain capillary endothelial cells; CRM197; Diphtheria toxin receptor; Drug targeting

Indexed keywords

EID: 84934437443     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-210-6_8     Document Type: Article

References (12)

1. de Boer AG, van der Sandt IC, Gaillard PJ. The role of drug transporters at the blood-brain barrier. Annu Rev Pharmacol Toxicol 2003;43:629-56.
2. de Boer AG, Gaillard PJ. Drug targeting to the brain. Annu Rev Pharmacol Toxicol 2007;47:9.1-9.33.
3. Gaillard PJ, Visser CC, de Boer AG. Targeted delivery across the blood-brain barrier. Expert Opin Drug Deliv 2005;2(2):299-309.
4. Gaillard PJ, Brink A, de Boer AG. Diphtheria-toxin receptor-targeted brain drug delivery. Int Congress Series 2005;1277(11):185-98.
5. Gaillard PJ, Voorwinden LH, Nielsen JL, Ivanov A, Atsumi R, Engman H, Ringbom C, de Boer AG, Breimer DD. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci 2001;12(3):215-22.
6. Franke H, Galla HJ, Beuckmann CT. An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res 1999;818(1):65-71.
7. Gaillard PJ, van der Sandt IC, Voorwinden LH, Vu D, Nielsen JL, de Boer AG, Breimer DD. Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier. Pharm Res 2000;17(10):1198-205.
8. van der Sandt IC, Gaillard PJ, Voorwinden HH, de Boer AG, Breimer DD. P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier. Pharm Res 2001;18(5):587-92.
9. Gaillard PJ, de Boer AB, Breimer DD. Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro. Microvasc Res 2003;65(1):24-31.
10. Roux F, Couraud PO. Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions. Cell Mol Neurobiol 2005;25(1):41-58.
11. Weksler BB, Subileau EA, Perriere N, Chameau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005;19(13):1872-4.
12. Gaillard PJ, de Boer AG. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci 2000;12(2):95-102.